Anthem Biosciences Limited
NSE: ANTHEM | Information Technology
Market Fundamentals
Stock Intelligence & News
Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target
Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is bullish on the company’s integrated CRDMO model, strong return ratios and growth prospects, forecasting 18% revenue CAGR through FY29. Key triggers include new commercial molecules and biosimilar launches, while customer concentration and high capex remain key risks.
Read Full Analysis →Stock Picks Today: Hindustan Zinc, Anthem Bioscience, Crompton Consumer, Adani Green, And More On Brokerages' Radar
Check out the top stock calls, upgrades, downgrades, and target price revisions from leading brokerages ahead of today's trade.
Read Full Analysis →Anthem Biosciences Limited
Anthem Biosciences Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Anthem Biosciences Limited
Anthem Biosciences Limited has submitted the Exchange the voting results and a copy Srutinizers report of the 20th Annual General Meeting held on July 22, 2026. |SUBJECT: Shareholders meeting
Read Full Analysis →Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip
Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip
Read Full Analysis →Earnings call transcript: Anthem Biosciences Q1 2027 revenue slips as stock falls 2.2%
Earnings call transcript: Anthem Biosciences Q1 2027 revenue slips as stock falls 2.2%
Read Full Analysis →Anthem Biosciences Limited
Financial Results |Meeting Date: 21-Jul-2026
Read Full Analysis →Anthem Biosciences Limited
Board Meeting Intimation |Meeting Date: 21-Jul-2026
Read Full Analysis →Anthem Biosciences Limited
Anthem Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Anthem Biosciences Limited
Anthem Biosciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Get instant alerts when ANTHEM breaks news
Join investors who track Anthem Biosciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for ANTHEM?
ANTHEM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Anthem Biosciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding ANTHEM to your custom watchlist.